ArticleFrontiers in immunology2025

Enhancing cDC1-mediated anti-tumor immunity limits tumor progression and potentiates anti-PD-1 therapy in intrahepatic cholangiocarcinoma.

Dong-Ni Pei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.